Table 1 Comparisons of baseline characteristics among three groups
Parameters | HD group (n = 14) | CVVH/HD group (n = 9) | SLED/HD group (n = 12) | P-value |
|---|---|---|---|---|
Age (year) | 52.5(50–60) | 55(52–59) | 48.5(44–54.5) | 0.169* |
Gender (Male/Female) | 8/6 | 5/4 | 5/7 | 0.759# |
Duration of disease onset to blood purification (hr) | 93.4 ± 13.9 | 96.8 ± 15.0 | 99.3 ± 17.2 | 0.622△ |
APACHE II score | 20.29 ± 2.33 | 22.33 ± 2.06 | 21.67 ± 1.87 | 0.072△ |
Mean arterial pressure (mmHg) (1 mmHg = 0.133 KPa) | 94.54 ± 27.17 | 88.48 ± 21.87 | 86.33 ± 21.38 | 0.669△ |
WBC (×109/L) | 28.41 ± 5.33 | 25.58 ± 4.81 | 27.19 ± 3.96 | 0.389△ |
Hb (g/L) | 95.29 ± 19.44 | 90.11 ± 20.97 | 93.25 ± 18.79 | 0.827△ |
Plt (×109/L) | 81.93 ± 16.53 | 83.80 ± 19.70 | 85.73 ± 17.37 | 0.773△ |
Urine volume (ml/h) | 9.43 ± 3.64 | 8.18 ± 3.94 | 8.78 ± 3.21 | 0.725△ |
Scr (μmol/L) | 779.2 ± 124.1 | 822.4 ± 140.9 | 804.8 ± 117.4 | 0.715△ |
TB (μmol/L) | 62.42 ± 21.00 | 68.29 ± 18.04 | 66.09 ± 19.31 | 0.771△ |
ALT(U/L) | 1320.9 ± 409.7 | 1296.0 ± 444.7 | 1127.4 ± 356.3 | 0.443△ |
LDH (U/L) | 4992.8 ± 1422.9 | 5281.7 ± 1173.0 | 4771.7 ± 1322.0 | 0.688△ |
Creatine kinase (U/L) | 21,506 ± 8977 | 19,889 ± 9032 | 18,346 ± 6828 | 0.631△ |
Creatine kinase-MB (U/L) | 779.8 ± 228.8 | 737.9 ± 198.9 | 758.4 ± 207.8 | 0.899△ |
NT-proBNP (pg/mL) | 3245.6 ± 1127.7 | 3196.2 ± 1205.3 | 3289.1 ± 1419.6 | 0.815△ |
PT(s) | 24.69 ± 3.73 | 26.38 ± 4.49 | 23.06 ± 4.21 | 0.199△ |
APTT(s) | 48.55 ± 12.89 | 46.56 ± 8.11 | 50.63 ± 9.21 | 0.681△ |